LTP ltr pharma limited

Ann: Final Patients dosed in SPONTAN pivotal study, page-24

  1. 440 Posts.
    lightbulb Created with Sketch. 38
    when going for a patent, companies will claim as much as possible. They basically try to cover and get away with as much as possible. Then they narrow it and resubmit, sometimes multiple times until they find the sweet spot at the right time. This is not a unique strategy and one that their patent attorney would have recommended.

    You're ok at Googling but need to take it a step further to interpret. Get it interpreted from those with experience. I have done this with a medical researcher with experience in exactly this. I have also consulted two brokers and a biotech analyst at a mid sized broker with no conflict.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
29.0¢
Change
0.015(5.45%)
Mkt cap ! $32.46M
Open High Low Value Volume
27.5¢ 29.0¢ 27.5¢ $134.1K 482.9K

Buyers (Bids)

No. Vol. Price($)
1 50000 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 7400 2
View Market Depth
Last trade - 15.19pm 25/06/2025 (20 minute delay) ?
LTP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.